Isturisa
Payments companies reported to CMS as associated with Isturisa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Isturisa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Isturisa
These are the largest totals companies reported as associated with Isturisa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Elena Christofides | Columbus, OH | Endocrinology, Diabetes & Metabolism | $149,105.14 |
| Wenyu Huang | Chicago, IL | Endocrinology, Diabetes & Metabolism | $78,028.54 |
| Anthony Heaney | Los Angeles, CA | Endocrinology, Diabetes & Metabolism | $60,727.61 |
| Maria Fleseriu | Portland, OR | Endocrinology, Diabetes & Metabolism | $43,977.66 |
| Atil Kargi | Chapel Hill, NC | Endocrinology, Diabetes & Metabolism | $43,114.61 |
| Eduardo Luna | Edinburg, TX | Endocrinology, Diabetes & Metabolism | $35,253.45 |
| Oksana Hamidi | Dallas, TX | Endocrinology, Diabetes & Metabolism | $26,652.83 |
| Lewis Blevins | San Francisco, CA | Endocrinology, Diabetes & Metabolism | $24,699.20 |
| Lauren Gratian | Wilmington, NC | Endocrinology, Diabetes & Metabolism | $22,078.47 |
| Eugenio Angueira-Serrano | Miami, FL | Endocrinology, Diabetes & Metabolism | $17,652.62 |
Prescribed Isturisa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.